Subsequently, the BrdU assay was used to determine the effect of DNMT3A on HCC proliferation, and the results showed that overexpression of DNMT3A led to increased cell growth (*p<0.05, Figure 8C). The gene discussed is DNMT3A; the disease is hepatocellular carcinoma.